GYRE GYRE THERAPEUTICS INC
2026Q1 · CUSIP 403783103 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
55
Δ holders QoQ
+11
Breadth percentile
Top 27%
Whale holders
31
Δ whales
+5
Inst. holding value
$24M
New positions
15
Closed positions
4
Price momentum (1Q)
—
Put / Call
0/0
Breadth history (34 quarters)
Past Lit Events & Aftermath 0 lit events
No lit events in history
Options Sentiment
Put holders
0
QoQ: -1
Call holders
0
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.08
EPS YoY
-500.0%
Revenue (TTM)
$0.1B
Revenue YoY
+16.3%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)